Albright's Hereditary Osteodystrophy and Pseudohypoparathyroidism

ABSTRACT

Pseudohypoparathyroidism (PHP) and Albright's hereditary osteodystrophy (AHO) are not interchangeable terms. AHO describes a constellation of physical features, including short adult stature, obesity, brachydactyly, and ectopic ossifications. PHP means end-organ resistance to PTH and is subclassified into types Ia, Ib, and Ic and type II. Pseudopseudohypoparathyroidism (PPHP) is a term used for individuals with AHO who have normal end-organ responses to PTH. Both the PHPIa and PPHP forms of AHO result from heterozygous deactivating mutations in the GNAS1 gene associated with a 50% reduction in bioactivity of the Gsα protein that it encodes. The GNAS1 gene is subject to tissue-specific genomic imprinting. Patients with mutations on their maternally derived allele are likely to have associated PHPIa, whereas mutations on the paternal allele usually cause PPHP. Isolated PTH resistance (PHPIb) can result from mutations within the GNAS1 gene but is more commonly caused by epigenetic imprinting abnormalities affecting the upstream exon 1A. The causes of PHP type Ic and PHP type II are not yet clear, and the latter is likely to be heterogeneous.

KEYWORD

Albright's hereditary osteodystrophy - pseudohypoparathyroidism - Gs alpha - GNAS1 - imprinting

REFERENCES

• 1 Albright F, Burnett C H, Smith P H, Parson W. Pseudo-hypoparathyroidism-an example of "Seabright-Bantam syndrome."  Endocrinology . 1942;  30 922-932
• 2 Albright F, Forbes A P, Henneman P H. Pseudo-pseudohypoparathyroidism.  Trans Assoc Am Phys . 1952;  65 337-350
• 3 Lewin I G, Papapoulos S E, Tomlinson S, Hendy G N, O'Riordan J LH. Studies of hypoparathyroidism and pseudohypoparathyroidism.  QJM . 1978;  47 533-548
• 4 Tomlinson S, Barling P M, Albano J DM, Brown B L, O'Riordan J LH. The effects of exogenous parathyroid hormone on plasma and urinary adenosine 3',5'-cyclic monophosphate in man.  Clin Sci Molec Med . 1974;  47 481-492
• 5 Bourne H R, Stryer L. G proteins. The target sets the tempo [news].  Nature . 1992;  358 541-543
• 6 Levine M A, Downs Jr W R, Moses A M. Resistance to multiple hormones in patients with pseudohypoparathyroidism: association with deficient activity of guanine nucleotide regulatory protein.  Am J Med . 1983;  74 545-556
• 7 Spiegel A M, Weinstein L S. Pseudohypoparathyroidism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Bases of Inherited Disease, 7th ed New York: McGraw-Hill 1995: 3073-3089
• 8 Patten J L, Levine M A. Immunochemical analysis of the alpha-subunit of the stimulatory G-protein of adenylyl cyclase in patients with Albright's hereditary osteodystrophy.  J Clin Endocrinol Metab . 1990;  71 1208-1214
• 9 Levine M A, Ahn T G, Klupt S F. Genetic deficiency of the α subunit of the guanine nucleotide-binding protein Gs as the molecular basis for Albright hereditary osteodystrophy.  Proc Natl Acad Sci USA . 1988;  85 617-621
• 10 Kozasa T, Itoh H, Tsukamoto T, Kaziro Y. Isolation and characterization of the human Gsα gene.  Proc Natl Acad Sci USA . 1988;  85 2081-2085
• 11 Aldred M A, Trembath R C. Activating and inactivating mutations in the human GNAS1 gene.  Hum Mutat . 2000;  16 183-189
• 12 Yu S, Yu D, Hainline B E. A deletion hotspot in exon 7 of the Gsα gene (GNAS1) in patients with Albright's hereditary osteodystrophy.  Hum Mol Genet . 1995;  4 2001-2002
• 13 Wilson L C, Oude Luttikhuis E M M, Clayton P T, Fraser W D, Trembath R C. Parental origin of Gsα mutations-evidence for imprinting in Albright hereditary osteodystrophy.  J Med Genet . 1994;  31 835-839
• 14 Davies S J, Hughes H E. Imprinting in Albright's hereditary osteodystrophy [review].  J Med Genet . 1993;  30 101-103
• 15 Schuster V, Kress W, Kruse K. Paternal and maternal transmission of pseudohypoparathyroidism type Ia in a family with Albright hereditary osteodystrophy: no evidence of genomic imprinting.  J Med Genet . 1994;  31 84
• 16 Hayward B E, Barlier A, Korbonits M. Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly.  J Clin Invest . 2001;  107 R31-R36
• 17 Germain-Lee E L, Ding C L, Deng Z. Paternal imprinting of Galpha(s) in the human thyroid as the basis of TSH resistance in pseudohypoparathyroidism type 1a.  Biochem Biophys Res Commun . 2002;  296 67-72
• 18 Yu S, Yu D, Lee E. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein α-subunit (Gsα) knockout mice is due to tissue-specific imprinting of the Gsα gene.  Proc Natl Acad Sci USA . 1998;  95 8715-8720
• 19 Hayward B E, Moran V, Strain L, Bonthron D T. Bidirectional imprinting of a single gene: GNAS1 encodes maternally, paternally, and biallelically derived proteins.  Proc Natl Acad Sci USA . 1998;  95 15475-15480
• 20 Liu J, Litman D, Rosenberg M J. A GNAS1 imprinting defect in pseudohypoparathyroidism type IB.  J Clin Invest . 2000;  106 1167-1174
• 21 Wu W I, Schwindinger W F, Aparicio L F, Levine M A. Selective resistance to parathyroid hormone caused by a novel uncoupling mutation in the carboxyl terminus of Gsα.  J Biol Chem . 2001;  276 165-171
• 22 Linglart A, Carel J C, Garabedian M. GNAS1 lesions in pseudohypoparathyroidism Ia and Ic: genotype phenotype relationship and evidence of the maternal transmission of the hormonal resistance.  J Clin Endocrinol Metab . 2002;  87 189-197
• 23 de Wijn M E, Steendijk R. Growth and maturation in pseudo-hypoparathyroidism; a longitudinal study in 5 patients.  Acta Endocrinol . 1982;  101 223-226
• 24 Fitch N. Albright's hereditary osteodystrophy: a review.  Am J Med Genet . 1982;  11 11-29
• 25 Steinbach H L, Young D A. The roentgen appearance of pseudohypoparathyroidism (PH) and pseudo-pseudohypoparathyroidism (PPH). Differentiation from other syndromes associated with short metacarpals, metatarsals, and phalanges.  AJR Am J Roentgenol . 1966;  97 49-66
• 26 Poznanski A K, Werder E A, Giedion A. The pattern of shortening of the bones of the hand in PHP and PPHP-a comparison with brachydactyly E, Turner syndrome, and acrodysostosis.  Radiology . 1977;  123 707-718
• 27 Illum F, Dupont E. Prevalences of CT-detected calcification in the basal ganglia in idiopathic hypoparathyroidism and pseudohypoparathyroidism.  Neuroradiology . 1985;  27 32-37
• 28 Prendiville J S, Lucky A W, Mallory S B. Osteoma cutis as a presenting sign of pseudohypoparathyroidism.  Pediatr Dermatol . 1992;  9 11-18
• 29 Steinbach H L, Rudhe U, Jonsson M, Young D A. Evolution of skeletal lesions in pseudohypoparathyroidism.  Radiology . 1965;  85 670-676
• 30 Wong S, Zakov Z N, Albert D M. Scleral and choroidal calcifications in a patient with pseudohypoparathyroidism.  Br J Ophthalmol . 1979;  63 177-180
• 31 Schuster V, Sandhage K. Intracardiac calcifications in a case of pseudohypoparathyroidism type Ia (PHP-Ia).  Pediatr Cardiol . 1992;  13 237-239
• 32 Farfel Z, Friedman E. Mental deficiency in pseudohypoparathyroidism type I is associated with Ns-protein deficiency.  Ann Intern Med . 1986;  105 197-199
• 33 Spranger J W. Skeletal dysplasias and the eye: Albright's hereditary osteodystrophy.  Birth Defects Original Article Series . 1969;  5 122-128
• 34 Koch T, Lehnhardt E, Bottinger H. Sensorineural hearing loss owing to deficient G proteins in patients with pseudohypoparathyroidism: results of a multicentre study.  Eur J Clin Invest . 1990;  20 416-421
• 35 Ritchie G M. Dental manifestations of pseudohypoparathyroidism.  Arch Dis Child . 1965;  40 565-572
• 36 Faull C M, Welbury R R, Paul B, Kendall-Taylor P. Pseudohypoparathyroidism: its phenotypic variability and associated disorders in a large family.  QJM . 1991;  78 251-264
• 37 Okada K, Iida K, Sakusabe N. Pseudohypoparathyroidism-associated spinal stenosis.  Spine . 1994;  19 1186-1189
• 38 Burnstein M I, Kottamasu S R, Pettifor J M. Metabolic bone disease in pseudohypoparathyroidism: radiologic features.  Radiology . 1985;  155 351-356
• 39 Kerr D, Hosking D J. Pseudohypoparathyroidism: clinical expression of PTH resistance.  QJM . 1987;  65 889-894
• 40 Shore E M, Ahn J, Jan de Beur S. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia.  N Engl J Med . 2002;  346 99-106
• 41 Weinstein L S, Shenker A, Gejman P V. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome.  N Engl J Med . 1991;  325 1688-1695
• 42 Lyons J, Landis C A, Harsh G. Two G protein oncogenes in human endocrine tumors.  Science . 1990;  249 655-659
• 43 Lania A, Mantovani G, Spada A. G protein mutations in endocrine diseases.  Eur J Endocrinol . 2001;  145 543-559
• 44 Oude Luttikhuis E M, Williams D K, Trembath R C. Isolated autosomal dominant type E brachydactyly: exclusion of linkage to candidate regions 2q37 and 20q13.  J Med Genet . 1996;  33 873-876
• 45 Wilson L C, Oude Luttikhuis E M M, Baraitser M, Kingston H M, Trembath R C. Normal erythrocyte membrane Gsα bioactivity in two unrelated patients with acrodysostosis.  J Med Genet . 1997;  34 133-136
• 46 Wilson L C, Leverton K, Oude Luttikhuis E M M. Brachydactyly and mental retardation: an Albright hereditary osteodystrophy-like syndrome localised to 2q37.  Am J Hum Genet . 1995;  56 400-407